| Entry |
|
|---|
| Name |
Alvocidib (USAN/INN) |
|---|
| Formula |
C21H20ClNO5
|
|---|
| Exact mass |
401.1030
|
|---|
| Mol weight |
401.84
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Antineoplastic
DG03138 CDK inhibitor
|
|---|
| Remark |
|
|---|
| Efficacy |
Antineoplastic, Cyclin-dependent kinase (CDK) inhibitor |
|---|
| Target |
|
|---|
| Brite |
Drug groups [BR:br08330]
Antineoplastic
DG03138 CDK inhibitor
DG02041 Alvocidib
D09868 Alvocidib
Target-based classification of drugs [BR:br08310]
Protein kinases
Serine/threonine kinases
CMGC group
CDK1
D09868 Alvocidib (USAN/INN)
CDK2
D09868 Alvocidib (USAN/INN)
CDK4
D09868 Alvocidib (USAN/INN)
CDK6
D09868 Alvocidib (USAN/INN)
CDK7
D09868 Alvocidib (USAN/INN)
Drug groups [BR:br08330]
Antineoplastic
DG03138 CDK inhibitor
DG02041 Alvocidib
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 28
1 C1y C 23.5900 -28.2800
2 C1x C 24.7800 -27.5100
3 C1x C 24.7800 -26.1100
4 N1y N 23.5900 -25.4100
5 C1x C 22.4000 -26.1800
6 C1y C 22.4000 -27.5800
7 C1a C 23.5900 -24.0800
8 C8y C 24.7800 -30.3800
9 C8y C 24.7800 -31.7100
10 C8y C 26.0400 -32.4100
11 C8x C 27.2300 -31.7100
12 C8y C 27.2300 -30.3800
13 O2x O 26.0400 -29.6800
14 C8y C 28.4200 -29.6100
15 C8x C 29.6800 -30.3100
16 C8x C 30.8700 -29.6100
17 C8x C 30.8700 -28.2100
18 C8x C 29.6800 -27.5100
19 C8y C 28.4200 -28.2100
20 C8y C 23.5900 -29.6800
21 C8y C 22.4000 -30.3800
22 C8x C 22.4000 -31.7100
23 C8y C 23.5900 -32.4100
24 X Cl 27.2300 -27.5100
25 O1a O 21.1400 -29.6100
26 O1a O 23.5900 -33.8100
27 O5x O 26.0400 -33.8100
28 O1a O 21.1400 -28.2800
BOND 31
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 1 6 1
7 4 7 1
8 8 9 2
9 9 10 1
10 10 11 1
11 11 12 2
12 12 13 1
13 8 13 1
14 12 14 1
15 14 15 2
16 15 16 1
17 16 17 2
18 17 18 1
19 18 19 2
20 14 19 1
21 8 20 1
22 20 21 2
23 21 22 1
24 22 23 2
25 9 23 1
26 19 24 1
27 21 25 1
28 23 26 1
29 10 27 2
30 1 20 1 #Down
31 6 28 1 #Down
|
|---|